Resolvin D3 (RvD3; 100 ng/100 µl; IP; daily for 6 days) alleviates arthritis progression, reduces edema and limits leukocyte numbers in murine K/BxN-serum induced arthritis.
Animal Model: |
Male C57Bl/6 mice (12 weeks old) or ALX/fpr2/3 KO mice |
Dosage: |
100 ng/100 µl |
Administration: |
IP; daily for 6 days |
Result: |
Alleviated arthritis progression, reduced edema and limited leukocyte numbers in murine K/BxN-serum induced arthritis.
|